Joint Commission Sentinel Event Alert #61 - Managing the Risks of Direct Oral Anticoagulants

Published: 08/01/2019

  • The Joint Commission
Relevant To:
  • Dialysis Facilities,
  • Medical Office,
  • Critical Access Hospitals,
  • Home Health,
  • Hospitals,
  • Long Term Care,
  • Ambulatory Care,
  • Office-Based Surgery,
  • Clinical Lab,
  • Pharmacy,
  • Hospice,
  • Rural Health Clinics

The Joint Commission has issued Sentinel Event Alert #61 which reviews strategies for managing the risks associated with use of direct oral anticoagulants (DOAC). According to TJC, anticoagulants, as a medication class, are among those most frequently involved in error resulting in death or serious harm. However, TJC believes that with appropriate preparation and treatment the potentially deadly consequences of DOACs can be avoided.

The benefit of DOACs is that they are easy to use for patient

Sign Up for Free Trial